Risk factors for schizophrenia--all roads lead to dopamine.
about
The myth of schizophrenia as a progressive brain diseaseDevelopmental origins of brain disorders: roles for dopaminePolysialic acid is required for dopamine D2 receptor-mediated plasticity involving inhibitory circuits of the rat medial prefrontal cortexEpigenetics, stress, and their potential impact on brain network function: a focus on the schizophrenia diathesesGABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implicationsThe role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsNew atypical antipsychotics for schizophrenia: iloperidoneAssociations between DRDs and schizophrenia in a Korean population: multi-stage association analysesReduced capacity but spared precision and maintenance of working memory representations in schizophrenia.Paliperidone: the evidence of its therapeutic value in schizophrenia.Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.Cholecystokinin A receptor (CCKAR) gene variation is associated with language lateralizationAnxiety interacts with expressed emotion criticism in the prediction of psychotic symptom exacerbationThe epidemiology of schizophrenia: replacing dogma with knowledgeSchizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models.Dopaminergic basis of the psychosis-prone personality investigated with functional magnetic resonance imaging of procedural learningCannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophreniaIloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?The Impact of Maternal Vitamin D Status on Offspring Brain Development and Function: a Systematic ReviewCerebrospinal fluid: identification of diagnostic markers for schizophrenia.Life events and high-trait reactivity together predict psychotic symptom increases in schizophrenia.The audacity of proteomics: a chance to overcome current challenges in schizophrenia research.Lurasidone for schizophrenia: what's different?Structural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders.The neuropsychiatry of inborn errors of metabolism.What can we learn about schizophrenia from studying the human model, drug-induced psychosis?The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study.Bridging the gap between research into biological and psychosocial models of psychosis.BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory.Functional -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population.Lateral ventricle differences between first-episode schizophrenia and first-episode psychotic bipolar disorder: A population-based morphometric MRI study.Behavioral and neurochemical changes induced by repetitive combined treatments of ketamine and amphetamine in mice.Integrated Post-GWAS Analysis Sheds New Light on the Disease Mechanisms of Schizophrenia.Vulnerability of the mesencephalic dopaminergic neurons of the human neonate to prolonged perinatal hypoxia: an immunohistochemical study of tyrosine hydroxylase expression in autopsy material.The social determinants of psychosis in migrant and ethnic minority populations: a public health tragedy.Maternal Vitamin D Prevents Abnormal Dopaminergic Development and Function in a Mouse Model of Prenatal Immune Activation.Associations between psychotic-like symptoms and inattention/hyperactivity symptomsA potential link between gambling addiction severity and central dopamine levels: Evidence from spontaneous eye blink rates
P2860
Q24067152-2D0DEC89-851B-4709-BBF4-16A1D890CE51Q27024247-8A85832E-6B61-4618-B38A-C0D6B8F7ED7BQ27310462-CFDD6410-6038-45BD-A62B-026F83245C20Q28388390-89E8286B-C95E-474C-BD40-7C4F3A7CFAF9Q30376372-421EBF96-0BA1-453A-A40D-CC106BC31772Q30437188-4CD3B4DC-12A2-459D-981B-64ED351E08F6Q30476813-3A9162D0-B69D-4369-9B3E-D276B4D89C56Q30482195-A1C0FCA0-042B-4026-AB6A-8ED341516B4EQ33778087-BB4E5F90-A11A-4F8E-8B47-95880BB2BE08Q33906454-002A338B-1DA2-48D9-B803-8FA1657D4C9DQ34449894-2A0067E0-DA6C-47DD-8E48-74BD41555E5FQ34509725-C30FAF31-334E-4F35-9B1A-3B999FF6D3C3Q34558539-D781A034-DE72-4385-B42D-91FBC7C79694Q34830647-14B5FCE7-C0DB-4FFF-BC21-7EE691D2D1A1Q35237282-151E956C-634E-4607-9F4D-20E5381191F0Q35844335-EADC7AE9-DEA1-430A-BAF1-F5D12F20BB44Q36765010-EDCC7A17-AAF6-4C2C-90AE-C89B28193C46Q36864001-76B39922-82B8-4714-88A8-8A8E1F828862Q37019129-C701EF49-6C3B-430E-9E2D-3CA09C4CF933Q37038991-5C2F5859-D3FF-4D70-8DFD-28BD0C054F18Q37089776-2C05CF6D-4256-4C31-A45F-213ABBE95341Q37118995-B943AE2C-BBFF-4042-A23C-EA71162ABDB0Q37159581-FBBF58C4-B31A-4E9B-90A0-F780DED0BCA9Q37636121-C1063AF0-6E9B-432E-9D80-11871AB08E4DQ37987985-4B4878D7-FB81-4A3D-8E9C-2E7E73376F09Q38077106-22C23B42-8BC9-4779-84BE-43EE9410498CQ38108763-E36D7C36-958D-406B-A72E-E31AB19417E4Q38153344-721B71BF-1EA0-40BA-B279-5003F564BD1EQ39257773-BB1AA7FC-0332-45E7-AEC0-93C7CED70FC7Q41458505-F8403989-C5F8-4D72-96C7-6BA28812DDF6Q42157677-1F2B7BEC-0943-4C60-BB0D-745A7035B211Q43848842-041EA332-1467-4F9A-B1A9-9EADBC8457E5Q43973870-30F2E047-EC68-45F6-9EDD-045F553016D9Q47828024-2D12DB30-C32F-47FC-8F78-FCE4F08C5EE6Q47911349-D49E8E74-6E93-4DC7-AFB9-2F0050F09528Q48130399-3F836E81-0FEC-414F-9F6A-53A177824A34Q51870900-C344EB31-4A6C-45FB-BD8F-39A629DB9B6DQ55430762-A1A232D8-62BE-442C-B3BF-C73C6ED3A930Q57118535-BB8E38AA-8CF0-40B6-9777-9F32B349E754Q58761966-2B234437-F7B1-4040-81AF-15ACC0213E6D
P2860
Risk factors for schizophrenia--all roads lead to dopamine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Risk factors for schizophrenia--all roads lead to dopamine.
@en
type
label
Risk factors for schizophrenia--all roads lead to dopamine.
@en
prefLabel
Risk factors for schizophrenia--all roads lead to dopamine.
@en
P1476
Risk factors for schizophrenia--all roads lead to dopamine.
@en
P2093
Marta Di Forti
P304
P356
10.1016/J.EURONEURO.2007.02.005
P407
P478
17 Suppl 2
P577
2007-03-01T00:00:00Z